Cisco Systems showcased robust revenue growth and strategic advancements in AI and cybersecurity.

COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company valued at $7.15 billion, has initiated a share ...

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...

An announcement from Epwin Group plc ( ($GB:EPWN) ) is now available. Epwin Group Plc has conducted a share repurchase transaction, buying back ...

NORTH CANTON − Diebold Nixdorf on Wednesday announced a $100 million share repurchase program, its first stock buyback. The ...

Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

First, sign in to your Flipkart account and select My Orders from the drop-down menu. Here, you can view your previous ...

Every year, nearly 30,000 new products hit the shelves. To help shoppers navigate this sea of possibilities, Newsweek has ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Good afternoon, ladies and gentlemen, and welcome to the Good Times Restaurants Inc. Fiscal 2025 First Quarter Earnings Call.